Broadwood Partners, L.P. - Mar 23, 2022 Form 4 Insider Report for Lineage Cell Therapeutics, Inc. (LCTX)

Role
Director, 10%+ Owner
Signature
Broadwood Partners, L.P., By Broadwood Capital, Inc., By: /s/ Neal C. Bradsher, President
Stock symbol
LCTX
Transactions as of
Mar 23, 2022
Transactions value $
$1,317,667
Form type
4
Date filed
3/25/2022, 05:56 PM
Previous filing
Oct 1, 2021
Next filing
Apr 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LCTX Common Shares Purchase $355K +260K +0.76% $1.37 34.3M Mar 23, 2022 Direct F1, F2
transaction LCTX Common Shares Purchase $0 0 0% $0.00* 34.3M Mar 23, 2022 See Footnote F1
transaction LCTX Common Shares Purchase $284K +200K +0.58% $1.42 34.5M Mar 24, 2022 Direct F1, F3
transaction LCTX Common Shares Purchase $0 0 0% $0.00* 34.5M Mar 24, 2022 See Footnote F1
transaction LCTX Common Shares Purchase $678K +470K +1.36% $1.44 34.9M Mar 25, 2022 Direct F1, F4
transaction LCTX Common Shares Purchase $0 0 0% $0.00* 34.9M Mar 25, 2022 See Footnote F1
holding LCTX Common Shares 87.6K Mar 23, 2022 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F2 This constitutes the weighted average purchase price. The prices range from $1.33 to $1.38. The Reporting Person will provide upon request by the Securities and Exchange Commission staff (the "SEC Staff"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F3 This constitutes the weighted average purchase price. The prices range from $1.37 to $1.44. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F4 This constitutes the weighted average purchase price. The prices range from $1.36 to $1.50. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F5 These securities are owned by Neal C. Bradsher in his personal capacity.